Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Nonalcoholic Fatty Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01854463
What this trial is testing

The Effect of Vitamin D Supplementation in Type 2 Diabetes

Who this might be right for
DIABETES MELLITUS
Chuncheon Sacred Heart Hospital 158
Not applicableNot Yet RecruitingNCT05857319
What this trial is testing

Study Consortium for Evaluation of RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

Who this might be right for
Overweight and ObesityCardiovascular DiseasesMetabolic Disease+4 more
Groupe Éthique et Santé 10,000
Not applicableLooking for participantsNCT07083336
What this trial is testing

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Who this might be right for
Type 2 Diabetes MellitusMetabolic Dysfunction-associated Steatotic Liver Disease
State Key Laboratory of Subhealth Intervention Technology 120
Not applicableUnknownNCT02285218
What this trial is testing

Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD

Who this might be right for
Non-alcoholic Fatty Liver DiseaseType 2 DiabetesMetabolic Syndrome
Yonsei University 200
Early research (Phase 1)Study completedNCT03060538
What this trial is testing

A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabetes Mellitus, Type 2Non-Alcoholic Fatty Liver Disease
Genentech, Inc. 154
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Not applicableStudy completedNCT05946148
What this trial is testing

Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Steatosis
National and Kapodistrian University of Athens 78
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Post-approval studies (Phase 4)Study completedNCT01002547
What this trial is testing

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Who this might be right for
Nonalcoholic Steatohepatitis
VA Office of Research and Development 105
Testing effectiveness (Phase 2)WithdrawnNCT03291249
What this trial is testing

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDT2DM (Type 2 Diabetes Mellitus)
Tiziana Life Sciences LTD
Not applicableStudy completedNCT01317576
What this trial is testing

Optimizing the Beneficial Health Effects of Exercise for Diabetes: Focus on the Liver!

Who this might be right for
Diabetes Mellitus, Type 2Non-alcoholic Fatty Liver DiseaseObesity
Bram Brouwers 81
Not applicableStudy completedNCT04999124
What this trial is testing

Characteristics of NAFLD Among Type 2 Diabetes Patients

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
Ziekenhuis Oost-Limburg 1,762
Testing effectiveness (Phase 2)UnknownNCT04702490
What this trial is testing

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more
Metacrine, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT03205150
What this trial is testing

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Who this might be right for
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 107
Not applicableStudy completedNCT04263376
What this trial is testing

Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLD

Who this might be right for
ObesityDiabetes Mellitus, Type 2NAFLD
The Cleveland Clinic 18
Testing effectiveness (Phase 2)Ended earlyNCT01842282
What this trial is testing

Amlexanox for Type 2 Diabetes and Obesity

Who this might be right for
Diabetes Mellitus Type 2Non Alcoholic Fatty Liver DiseaseObesity
University of Michigan 7
Next Page